Control of Healthcare-Associated Methicillin-ResistantStaphylococcus aureus

  • Jan A.J.W. Kluytmans
  • Bram M.W. Diederen


As long as we are able to identify the causative microorganism for infections, Staphylococcus aureus has been the most important cause of nosocomial infections (Archer 2000). The consequences of infections are severe, especially when there is no effective antimicrobial treatment available. In 1941 the mortality rate of S. aureus bacteremia at the Boston City hospital was reported to be 82% (Skinner and Keefer 1941).


Staphylococcus Aureus Hand Hygiene Methicillin Resistance mecA Gene Vancomycin Resistant Enterococcus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albert RK, Condie F (1981) Handwashing patterns in medical intensive-care units. N Engl J Med 304:1465–1466.PubMedCrossRefGoogle Scholar
  2. Anonymous (1995) Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 23:87–94.CrossRefGoogle Scholar
  3. Archer GL (2000) Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis 26:1179–1181.CrossRefGoogle Scholar
  4. Archer GL, Niemeyer DM (1994) Original evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol 2:343–347.CrossRefPubMedGoogle Scholar
  5. Bassetti S, Sherertz RJ, Pfaller MA (2003) Airborne dispersal of Staphylococcus aureus associated with symptomatic rhinitis allergica. Ann Intern Med 139:W–W60.PubMedGoogle Scholar
  6. Beaujean DJMA, Tiemersma EW, de Neeling AJ, Wannet WJB (2005) Nationale MRSA-surveillance nieuwe stijl: de resultaten na een half jaar. Infectieziektenbulletin 16: 113–116.Google Scholar
  7. Bonten MJ, Austin DJ, Lipsitch M (2001) Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clin Infect Dis 33:1739–1746.CrossRefPubMedGoogle Scholar
  8. Boyce JM (1998) Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA 279:623–624.CrossRefPubMedGoogle Scholar
  9. Boyce JM, Potter-Bynoe G, Chenevert C, King T (1997) Environmental contamination due to methicillin-resistant Staphylococcus aureus: Possible infection control implications. Infect Control Hosp Epidemiol 18:622–627.CrossRefPubMedGoogle Scholar
  10. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F (2004) Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J Infect Dis 190:1730–1738.CrossRefPubMedGoogle Scholar
  11. Chambers HF (1997) Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781–791.PubMedGoogle Scholar
  12. Cooper BS Medley GF, Stone SP, kibbler CC, Coolkson BD, Roberts JA, Duckworth G, Lai R, Ebrahim S (2004) Methcillin-resistant Staphylococcus aureus in hospitals and the community: stealth dnamics and control catastrophes. Proc Natl Acad Sci USA 101:10223–10228.CrossRefPubMedGoogle Scholar
  13. Cookson B, Peters B, Webster M, Phillips I, Rahman M, Noble W (1989) Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 27:141–146.Google Scholar
  14. Cosgrove SE, Qi Y, Kaye KS, Harbath S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166–174.CrossRefPubMedGoogle Scholar
  15. Crossley K, Landesman B, Zaske D (1979). An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies. J Infect Dis 139:280–287.PubMedGoogle Scholar
  16. Crowcroft NS, Lamagni TL, Rooney C, Catchpole M, Duckworth G (2003) Mortality from methicillin resistant Staphylococcus aureus in England and Wales [electronic response to Howard et al. Mortality from methicillin resistant Staphylococcus aureus,].
  17. Davies RR, Noble WC (1963) Dispersal of staphylococci on desquamated skin. Lancet 324:1111.CrossRefGoogle Scholar
  18. Deresinski S (2005) Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40:562–573.CrossRefPubMedGoogle Scholar
  19. Diederen B, van Duijn I, van Belkum A, Willemse P, van Keulen P, Kluytmans J (2005) Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:1925–1927.CrossRefPubMedGoogle Scholar
  20. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M; SENTRY Partcipants Group (2001) Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32: S114–S132.CrossRefPubMedGoogle Scholar
  21. Dowling HF (1961) The new penicillins. Clin Pharmacol Ther 2:572–580.PubMedGoogle Scholar
  22. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 99:768–792.CrossRefGoogle Scholar
  23. Gardam M, Brunton J, Willey B, McGeer A, Low D, Conly J (2001) A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 22:152–156.CrossRefPubMedGoogle Scholar
  24. Garner JS (1996) Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 17:53–80.CrossRefPubMedGoogle Scholar
  25. Hancock RE (2005) Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect Dis 5:209–218.CrossRefPubMedGoogle Scholar
  26. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D (1999) Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43:1412–1416.PubMedGoogle Scholar
  27. Hare R, Thomas CG (1956) The transmission of Staphylococcus aureus. Br Med J 12:840–844.CrossRefGoogle Scholar
  28. Hill DA, Herford T, Parratt D (1998) Antibiotic usage and methicillin-resistant Staphylococcus aureus: An analysis of causality. J Antimicrob Chemother 42:676–677.CrossRefPubMedGoogle Scholar
  29. Huletsky A, Lebel P, Picard FJ, Bernier M, Gagnon M, Boucher N, MG (2005) Identification of methicillin resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis 40:976–81CrossRefPubMedGoogle Scholar
  30. Jevons MP (1961) “Celbenin”-resistant staphylococci. Br Med J 1:124–125.CrossRefGoogle Scholar
  31. Kaiser AM, Schultsz C, Kruithof GJ, Debets-Ossenkop Y, Vandenbroucke-Grauls C (2004) Carriage of resistant microorganisms in repatriates from foreign hospitals to the Netherlands. Clin Microbiol Infect 10:972–979.CrossRefPubMedGoogle Scholar
  32. Karchmer TB (2005) Prevention of health care-associated methicillin-resistant Staphylococcus aureus infections: Adapting to a changing epidemiology. Clin Infect Dis 41:167–169.CrossRefPubMedGoogle Scholar
  33. Katayama Y, Robinson DA, Enright MC, Chambers HF (2005) Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol 43:2380–2383.CrossRefPubMedGoogle Scholar
  34. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505–520.PubMedGoogle Scholar
  35. Landman D, Chockalingam M, Quale JM (1999) Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 28:1062–1066.CrossRefPubMedGoogle Scholar
  36. Loeb M, Main C, Walker-Dilks C, Eady A (2003) Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 4:CD003340.PubMedGoogle Scholar
  37. Malachowa N, Sabat A, Gniadkowski M, Krzyszton-Russjan J, Empel J, Miedzobrodzki J, Kosowska-Shick K, Appelbaum PC, Hryniewicz W (2005) Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol. 43:3095–3100.CrossRefPubMedGoogle Scholar
  38. Monnet DL (1998) Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control. Infect Control Hosp Epidemiol 19:552–559.CrossRefPubMedGoogle Scholar
  39. Monnet DL, MacKenzie FM, López-Lozano JM, Arielle Beyaert A, Camacho M, Wilson R, Stuart D, Gould IM (2004) Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000. Emerg Infect Dis 10:1432–1441.PubMedGoogle Scholar
  40. Mortimer EA, Wolinsky E, Gonzaga AJ, Rammelkamp CH (1966) Role of airborne transmission in staphylococcal infections. Br Med J 1:319–322.CrossRefPubMedGoogle Scholar
  41. Mulligan ME, Murray-Leisure KA, Ribner BS, Sandiford HC, John JF, Korvick JA, kauffman CA, Yu VL (1993) Methicillin resistant Staphylococcus aureus: a consesus review of the microbiology, pathogensis, and epidemiology with implications for prevention and management. Am J Med 94:313–323CrossRefPubMedGoogle Scholar
  42. Murray BE, Nannini EC (2005) Glycopeptides (vancomycin and teicoplanin), streptogramins (quinupristin-dalfopristin), and lipopeptides (daptomycin), in Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, ed 6. Philadelphia, Churchill Livingstone, pp 417–434.Google Scholar
  43. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–336.CrossRefPubMedGoogle Scholar
  44. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapetina E, Gemmen E (2005) The burden of Staphylococcus aureus infections on hospitals in the United States: An analysis of the 2000 and 2001 nationwide inpatient sample database. Arch Intern Med 165:1756–1761.CrossRefPubMedGoogle Scholar
  45. Sebille V, Chevret S, Valleron AJ (1997) Modelling the spread of resistant nosocomial pathogens in an intensive care unit. Infect Control Hosp Epidemiol 18:84–92.CrossRefPubMedGoogle Scholar
  46. Sheretz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, Thomas R, Gwaltney JM (1996) Cloud adult: The Staphylococcus aureus–virus interaction revisited. Ann Intern Med 124:539–547.PubMedGoogle Scholar
  47. Shinefield H, Black S, Fattom A, Horwith G (2002) Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346:491–496.CrossRefPubMedGoogle Scholar
  48. Skinner D, Keefer CS (1941) Significance of bacteremia caused by Staphylococcus aureus. Arch Intern Med 68:851–875.Google Scholar
  49. Solberg CO (2000) Spread of Staphylococcus aureus in hospitals: Causes and prevention. Scand J Infect Dis 32:587–595.CrossRefPubMedGoogle Scholar
  50. Stewart GT, Holt RJ (1963) Evolution of natural resistance to the newer penicillin. Br Med J 1:308–311.CrossRefPubMedGoogle Scholar
  51. Stone PW, Larson E, Kawar LN (2002) A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am J Infect Control 30:145–152.CrossRefPubMedGoogle Scholar
  52. Struelens J, Ronveaux O, Jans B, Mertens R (1996) Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, l’Etude et la Prevention des Infections Hospitalieres. Infect Control Hosp Epidemiol 17:503–508.CrossRefPubMedGoogle Scholar
  53. Tiemersma EW, Bronzwar SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H; European Antimicrobial Resistance Surveillance System Participants (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10:1627–1634.PubMedGoogle Scholar
  54. van Griethuysen A, de Neeling H, Vandenbroucke-Grauls C, Vos G, Kluytmans J (2003) Richtlijn detectie van meticillineresistente Staphylococcus aureus in Nederland. Ned Tijdschr Med Microbiol 11:58–65.Google Scholar
  55. van Ogtrop ML (1995) Effect of broth enrichment cultures on ability to detect carriage of Staphylococcus aureus. Antimicrob Agents Chemother 39:2169.PubMedGoogle Scholar
  56. Verhoef J, Beaujean D, Blok H, Baars A, Meyler A, van der Werken C, Weersink A (1999) A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 18:461–466.CrossRefPubMedGoogle Scholar
  57. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13:50–55.CrossRefPubMedGoogle Scholar
  58. Vriens MR, Fluit AC, Troelstra A, Verhoef J, van der Werken C (2002) Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit? Infect Control Hosp Epidemiol 23:491–494.CrossRefPubMedGoogle Scholar
  59. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA (1991) Methicillin-resistant Staphylococcus aureus: Implications for the 1990s and effective control measures. Am J Med 91(3B):221S–227S.CrossRefPubMedGoogle Scholar
  60. Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, Kluytmans JA, van Keuten PH, Verbrugh HA. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004 Apr;56(4)321–5.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jan A.J.W. Kluytmans
    • 1
  • Bram M.W. Diederen
    • 2
  1. 1.Laboratory of Microbiology and Infection ControlAmphia HospitalBredaThe Netherlands
  2. 2.Laboratory of Medical Microbiology and ImmunologySt. Elisabeth HospitalTilburgThe Netherlands

Personalised recommendations